+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiopharmaceuticals Market Size, Share & Trends Analysis Report 2026-2040

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 6292273
The global prebiotic ingredients market size was valued at USD 9.9 billion in 2025 and projected to grow from USD 11.0 billion in 2026 to USD 23.8 billion by 2033, at a CAGR of 10.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 51.2% in 2025. The market is witnessing strong growth as consumers increasingly prioritize gut health, immunity, and overall wellness, driving demand for functional foods and dietary supplements enriched with prebiotic fibers such as inulin, fructo-oligosaccharides (FOS), and galacto-oligosaccharides (GOS).

Food and beverage manufacturers are incorporating these ingredients into products like yogurt, nutrition bars, and functional beverages to meet the rising demand for clean-label, plant-based, and low-sugar alternatives. Additionally, increasing awareness of the gut microbiome’s role in digestive and metabolic health, along with the growing popularity of preventive healthcare among millennials and younger consumers, is further accelerating the market expansion.

The prebiotic ingredients industry is experiencing significant global growth, driven by continuous innovation in product formats, ingredient sources, and functional applications. Beyond traditional uses, niche segments such as prebiotic beverages, synbiotic formulations, and personalized nutrition solutions are gaining strong traction.

The global prebiotic ingredients industry is witnessing increasing demand as consumers place greater emphasis on gut health and its connection to overall well-being. In June 2026, NIQ reported that 65% of Canadian consumers considered gut health very important, while another 29% considered it important, indicating broad consumer awareness of digestive wellness. Moreover, 42% of consumers reported consuming prebiotic-rich foods, supporting the increasing incorporation of prebiotic ingredients into everyday food and beverage products.

Demand is also shifting toward food-based approaches to digestive wellness. NIQ reported in 2026 that half of the Canadian consumers viewed food-based approaches as the most effective way to improve gut health, compared with only 8% who primarily relied on supplements. This preference is creating opportunities for prebiotic ingredients in everyday foods and beverages rather than limiting their use to the dietary supplement category.

One of the main drivers is increasing consumer preference for organic and healthy food items, especially those made using clean-label, plant-based, and reduced-calorie ingredients. Prebiotics can be considered natural products because they come from plant sources like chicory roots and whole grains. Many consumers today prefer food products that do not contain artificial preservatives, flavors, or colors. Food processors are increasingly adding prebiotic ingredients to food products to replace unhealthy sugar and fat.

The application scope of prebiotic ingredients is also expanding into beverages. SPINS reported that diet and alternative sodas containing prebiotics and fiber accounted for only 6% of the total beverage market but generated 27% of beverage growth, highlighting the disproportionate contribution of prebiotic- and fiber-positioned products to category expansion. These trends will continue to shape the market in the years ahead, while ongoing advances in ingredient properties will further promote the market.

Global Prebiotic Ingredients Market Report Segmentation

This report forecasts revenue growth at the global, regional & country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the prebiotic ingredients market report based on type, application, and region:

Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Inulin
  • Oligosaccharide (MOS/GOS/FOS)
  • Others

Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Food & Beverage
  • Dietary Supplements
  • Others

Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Central & South America
  • Brazil
  • Middle East & Africa
  • South Africa
  • UAE

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. The internal database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Radiopharmaceuticals Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Radiopharmaceuticals Market: Product Business Analysis
4.1. Product Market Share, 2025 & 2040
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, Product, 2021 to 2040 (USD Billion)
4.4. Diagnostic Radiopharmaceuticals
4.4.1. Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2. PET Radiopharmaceuticals
4.4.2.1. PET Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.2. F-18 FDG Radiopharmaceuticals
4.4.2.2.1. F-18 FDG Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.3. Ga-68-based Radiopharmaceuticals
4.4.2.3.1. Ga-68-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.4. F-18 PSMA-based Radiopharmaceuticals
4.4.2.4.1. F-18 PSMA-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.5. F-18 NaF Radiopharmaceuticals
4.4.2.5.1. F-18 NaF Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.6. F-18 Fluciclovine Radiopharmaceuticals
4.4.2.6.1. F-18 Fluciclovine Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.7. Rb-82-based Radiopharmaceuticals
4.4.2.7.1. Rb-82-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.8. N-13 Ammonia Radiopharmaceuticals
4.4.2.8.1. N-13 Ammonia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.9. Others
4.4.2.9.1. Others Market, 2021 - 2040 (USD Billion)
4.4.3. SPECT Radiopharmaceuticals
4.4.3.1. SPECT Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.2. Tc-99m-based Radiopharmaceuticals
4.4.3.2.1. Tc-99m-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.3. I-123-based Radiopharmaceuticals
4.4.3.3.1. I-123-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.4. In-111-based Radiopharmaceuticals
4.4.3.4.1. In-111-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.5. Tl-201-based Radiopharmaceuticals
4.4.3.5.1. Tl-201-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.6. Others
4.4.3.6.1. Others Market, 2021 - 2040 (USD Billion)
4.5. Therapeutic Radiopharmaceuticals
4.5.1. Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2. Beta Emitters
4.5.2.1. Beta Emitters Market, 2021 - 2040 (USD Billion)
4.5.2.2. Lu-177-based Radiopharmaceuticals
4.5.2.2.1. Lu-177-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2.3. I-131-based Radiopharmaceuticals
4.5.2.3.1. I-131-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2.4. Y-90-based Radiopharmaceuticals
4.5.2.4.1. Y-90-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2.5. Others
4.5.2.5.1. Others Market, 2021 - 2040 (USD Billion)
4.5.3. Alpha Emitters
4.5.3.1. Alpha Emitters Market, 2021 - 2040 (USD Billion)
4.5.3.2. Ra-223-based Radiopharmaceuticals
4.5.3.2.1. Ra-223-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.3.3. Ac-225-based Radiopharmaceuticals
4.5.3.3.1. Ac-225-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Chapter 5. Radiopharmaceuticals Market: Application Business Analysis
5.1. Application Market Share, 2025 & 2040
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, Application, 2021 to 2040 (USD Billion)
5.4. Diagnostic Radiopharmaceuticals
5.4.1. Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
5.4.2. Oncology Imaging
5.4.2.1. Oncology Imaging Market, 2021 - 2040 (USD Billion)
5.4.3. Cardiac Imaging
5.4.3.1. Cardiac Imaging Market, 2021 - 2040 (USD Billion)
5.4.4. Neurology Imaging
5.4.4.1. Neurology Imaging Market, 2021 - 2040 (USD Billion)
5.4.5. Endocrine Imaging
5.4.5.1. Endocrine Imaging Market, 2021 - 2040 (USD Billion)
5.4.6. Renal Imaging
5.4.6.1. Renal Imaging Market, 2021 - 2040 (USD Billion)
5.4.7. Infection & Inflammation Imaging
5.4.7.1. Infection & Inflammation Imaging Market, 2021 - 2040 (USD Billion)
5.4.8. Others
5.4.8.1. Others Market, 2021 - 2040 (USD Billion)
5.5. Therapeutic Radiopharmaceuticals
5.5.1. Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
5.5.2. Prostate Cancer
5.5.2.1. Prostate Cancer Market, 2021 - 2040 (USD Billion)
5.5.3. Neuroendocrine Tumors
5.5.3.1. Neuroendocrine Tumors Market, 2021 - 2040 (USD Billion)
5.5.4. Thyroid Disorders
5.5.4.1. Thyroid Disorders Market, 2021 - 2040 (USD Billion)
5.5.5. Bone Metastases
5.5.5.1. Bone Metastases Market, 2021 - 2040 (USD Billion)
5.5.6. Liver Cancer
5.5.6.1. Liver Cancer Market, 2021 - 2040 (USD Billion)
5.5.7. Others
5.5.7.1. Others Market, 2021 - 2040 (USD Billion)
Chapter 6. Radiopharmaceuticals Market: End Use Business Analysis
6.1. End Use Market Share, 2025 & 2040
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, End Use, 2021 to 2040 (USD Billion)
6.4. Hospitals
6.4.1. Hospitals Market, 2021 - 2040 (USD Billion)
6.5. Diagnostic Imaging Centers
6.5.1. Diagnostic Imaging Centers Market, 2021 - 2040 (USD Billion)
6.6. Ambulatory Surgery Centers
6.6.1. Ambulatory Surgery Centers Market, 2021 - 2040 (USD Billion)
6.7. Specialty Clinics & Cath Labs
6.7.1. Specialty Clinics & Cath Labs Market, 2021 - 2040 (USD Billion)
6.8. Academic & Research Institutes
6.8.1. Academic & Research Institutes Market, 2021 - 2040 (USD Billion)
Chapter 7. Radiopharmaceuticals Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2040
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2040:
7.4. North America
7.4.1. North America Radiopharmaceuticals Market Estimates and Forecasts, Country, 2021 - 2040 (USD Billion)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. Canada Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5. Europe
7.5.1. Europe Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. UK Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.7. Latin America
7.7.1. Latin America Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Brazil Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. Argentina Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Lantheus
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Curium
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. GE HealthCare
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Jubilant Radiopharma
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Blue Earth Diagnostics (Bracco)
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. NCM USA
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Novartis (Advanced Accelerator Applications / Endocyte)
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Bayer AG
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Telix Pharmaceuticals
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. AstraZeneca / Fusion Pharmaceuticals
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Eckert & Ziegler
8.5.11.1. Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. Sirtex Medical
8.5.12.1. Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives
8.5.13. Boston Scientific
8.5.13.1. Overview
8.5.13.2. Financial Performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic Initiatives
8.5.14. Actinium Pharmaceuticals
8.5.14.1. Overview
8.5.14.2. Financial Performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Radiopharmaceuticals Market, Region, 2021 - 2040 (USD Billion)
Table 4 Global Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 5 Global Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 6 Global Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 7 North America Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 8 North America Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 9 North America Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 10 North America Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 11 U.S. Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 12 U.S. Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 13 U.S. Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 14 Canada Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 15 Canada Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 16 Canada Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 17 Mexico Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 18 Mexico Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 19 Mexico Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 20 Europe Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 21 Europe Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 22 Europe Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 23 Europe Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 24 UK Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 25 UK Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 26 UK Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 27 Germany Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 28 Germany Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 29 Germany Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 30 France Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 31 France Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 32 France Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 33 Italy Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 34 Italy Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 35 Italy Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 36 Spain Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 37 Spain Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 38 Spain Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 39 Norway Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 40 Norway Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 41 Norway Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 42 Denmark Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 43 Denmark Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 44 Denmark Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 45 Sweden Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 46 Sweden Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 47 Sweden Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 48 Asia Pacific Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 49 Asia Pacific Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 50 Asia Pacific Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 51 Asia Pacific Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 52 Japan Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 53 Japan Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 54 Japan Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 55 China Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 56 China Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 57 China Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 58 India Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 59 India Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 60 India Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 61 Australia Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 62 Australia Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 63 Australia Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 64 South Korea Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 65 South Korea Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 66 South Korea Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 67 Thailand Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 68 Thailand Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 69 Thailand Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 70 Latin America Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 71 Latin America Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 72 Latin America Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 73 Latin America Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 74 Brazil Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 75 Brazil Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 76 Brazil Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 77 Argentina Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 78 Argentina Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 79 Argentina Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 80 Middle East & Africa Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 81 Middle East & Africa Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 82 Middle East & Africa Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 83 Middle East & Africa Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 84 South Africa Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 85 South Africa Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 86 South Africa Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 87 Saudi Arabia Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 88 Saudi Arabia Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 89 Saudi Arabia Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 90 UAE Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 91 UAE Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 92 UAE Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 93 Kuwait Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 94 Kuwait Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 95 Kuwait Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
List of Figures
Figure 1 Radiopharmaceuticals Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot
Figure 9 Competitive Landscape
Figure 10 Radiopharmaceuticals Market Dynamics
Figure 11 Radiopharmaceuticals Market: Porter’s Five Forces Analysis
Figure 12 Radiopharmaceuticals Market: PESTLE Analysis
Figure 13 Product Market, 2021 - 2040 (USD Billion)
Figure 14 Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 15 PET Radiopharmaceuticals, 2021 - 2040 (USD Billion)
Figure 16 F-18 FDG Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 17 Ga-68-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 18 F-18 PSMA-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 19 F-18 NaF Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 20 F-18 Fluciclovine Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 21 Rb-82-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 22 N-13 Ammonia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 23 Others Market, 2021 - 2040 (USD Billion)
Figure 24 SPECT Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 25 Tc-99m-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 26 I-123-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 27 In-111-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 28 Tl-201-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 29 Others Market, 2021 - 2040 (USD Billion)
Figure 30 Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 31 Beta Emitters Market, 2021 - 2040 (USD Billion)
Figure 32 Lu-177-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 33 I-131-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 34 Y-90-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 35 Others Market, 2021 - 2040 (USD Billion)
Figure 36 Alpha Emitters Market, 2021 - 2040 (USD Billion)
Figure 37 Ra-223-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 38 Ac-225-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 39 Application Market, 2021 - 2040 (USD Billion)
Figure 40 Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 41 Oncology Imaging Market, 2021 - 2040 (USD Billion)
Figure 42 Cardiac Imaging Market, 2021 - 2040 (USD Billion)
Figure 43 Neurology Imaging Market, 2021 - 2040 (USD Billion)
Figure 44 Endocrine Imaging Market, 2021 - 2040 (USD Billion)
Figure 45 Renal Imaging Market, 2021 - 2040 (USD Billion)
Figure 46 Infection & Inflammation Imaging Market, 2021 - 2040 (USD Billion)
Figure 47 Others Market, 2021 - 2040 (USD Billion)
Figure 48 Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 49 Prostate Cancer Market, 2021 - 2040 (USD Billion)
Figure 50 Neuroendocrine Tumors Market, 2021 - 2040 (USD Billion)
Figure 51 Thyroid Disorders Market, 2021 - 2040 (USD Billion)
Figure 52 Bone Metastases Market, 2021 - 2040 (USD Billion)
Figure 53 Liver Cancer Market, 2021 - 2040 (USD Billion)
Figure 54 Others Market, 2021 - 2040 (USD Billion)
Figure 55 End Use Market, 2021 - 2040 (USD Billion)
Figure 56 Hospitals Market, 2021 - 2040 (USD Billion)
Figure 57 Diagnostic Imaging Centers Market, 2021 - 2040 (USD Billion)
Figure 58 Ambulatory Surgery Centers Market, 2021 - 2040 (USD Billion)
Figure 59 Specialty Clinics & Cath Labs Market, 2021 - 2040 (USD Billion)
Figure 60 Academic & Research Institutes Market, 2021 - 2040 (USD Billion)
Figure 61 Radiopharmaceuticals Market Revenue, Region
Figure 62 Regional Marketplace: Key Takeaways
Figure 63 North America Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 64 U.S. Country Dynamics
Figure 65 U.S. Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 66 Canada Country Dynamics
Figure 67 Canada Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 68 Mexico Country Dynamics
Figure 69 Mexico Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 70 Europe Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 71 UK Country Dynamics
Figure 72 UK Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 73 Germany Country Dynamics
Figure 74 Germany Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 75 France Country Dynamics
Figure 76 France Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 77 Italy Country Dynamics
Figure 78 Italy Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 79 Spain Country Dynamics
Figure 80 Spain Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 81 Norway Country Dynamics
Figure 82 Norway Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 83 Sweden Country Dynamics
Figure 84 Sweden Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 85 Denmark Country Dynamics
Figure 86 Denmark Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 87 Asia Pacific Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 88 Japan Country Dynamics
Figure 89 Japan Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 90 China Country Dynamics
Figure 91 China Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 92 India Country Dynamics
Figure 93 India Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 94 Australia Country Dynamics
Figure 95 Australia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 96 South Korea Country Dynamics
Figure 97 South Korea Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 98 Thailand Country Dynamics
Figure 99 Thailand Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 100 Latin America Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 101 Brazil Country Dynamics
Figure 102 Brazil Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 103 Argentina Country Dynamics
Figure 104 Argentina Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 105 MEA Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 106 South Africa Country Dynamics
Figure 107 South Africa Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 108 Saudi Arabia Country Dynamics
Figure 109 Saudi Arabia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 110 UAE Country Dynamics
Figure 111 UAE Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 112 Kuwait Country Dynamics
Figure 113 Kuwait Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 114 Company Categorization
Figure 115 Company Market Position Analysis
Figure 116 Strategic Framework

Companies Mentioned

  • Lantheus
  • Curium
  • GE HealthCare
  • Jubilant Radiopharma
  • Blue Earth Diagnostics (Bracco)
  • NCM USA
  • Novartis (Advanced Accelerator Applications / Endocyte)
  • Bayer AG
  • Telix Pharmaceuticals
  • Eckert & Ziegler
  • Sirtex Medical
  • Boston Scientific
  • AstraZeneca / Fusion Pharmaceuticals
  • Actinium Pharmaceuticals